Document Detail


Thrombolytic therapy within one hour of the onset of acute myocardial infarction.
MedLine Citation:
PMID:  1946929     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Between 1986 and 1988, 239 consecutive patients with acute myocardial infarction received thrombolytic therapy up to 285 minutes after onset of symptoms; in 39 (17 with anterior infarction, 21 inferior, one lateral infarction) recombinant tissue plasminogen activator or anistreplase was administered a mean of 51 minutes (range 20-60 minutes) after the onset of symptoms. The patency rates (26 of 30; 87 per cent), rapid ST segment resolution (36 of 38; 95 per cent) and QRS score of less than or equal to 3 (28 of 38; 74 per cent) were statistically significantly higher for those seen and treated in the first hour in comparison with those seen and treated later. For those treated within the first hour mean peak creatine kinase was 1264 U/l for those with TIMI grade 2 or 3 (partial or complete perfusion) compared with 3005 U/l for those with TIMI grade 0 or 1 (no perfusion or penetration without perfusion) (p = 0.02): mean peak creatine kinase-MB for those with TIMI grade 2 or 3 perfusion was 115 U/l compared with 312 U/l for those with TIMI grade 0 or 1 (p = 0.01). Four of the 39 patients developed ventricular fibrillation following thrombolytic therapy, three within 24 hours of infarction and one following reinfarction on day 15. There were no significant bleeding complications. One patient died. Thrombolytic therapy within 1 hour of the onset of symptoms led to a very high angiographic patency rate, rapid ST segment resolution with preservation of left ventricular function. This therapy is without significant complications.
Authors:
A J McNeill; D J Flannery; C M Wilson; G W Dalzell; N P Campbell; M M Khan; G C Patterson; S W Webb; A A Adgey
Related Documents :
14988779 - Thrombolytic therapy in acute myocardial infarction.
2507069 - Role of the general practitioner in managing patients with myocardial infarction: impac...
17999899 - Thrombolytics in intraventricular hemorrhage.
17341789 - Global akinesis: inadvertent left ventricular "pseudoaneurysmogram".
24491229 - Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with i...
3592299 - Myocardial reperfusion by thrombolysis after acute total left main artery occlusion--a ...
12823649 - Narrowing gender differences in procedure use for acute myocardial infarction: insights...
2644829 - Altered myocardial states. the stunned and hibernating myocardium.
9812789 - Effect of amino acid cardioplegia on myocardial metabolism and function of ischemic can...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Quarterly journal of medicine     Volume:  79     ISSN:  0033-5622     ISO Abbreviation:  Q. J. Med.     Publication Date:  1991 Jun 
Date Detail:
Created Date:  1991-11-27     Completed Date:  1991-11-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0401027     Medline TA:  Q J Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  487-94     Citation Subset:  IM    
Affiliation:
Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anistreplase / administration & dosage*
Creatine Kinase / blood
Drug Administration Schedule
Heart / physiopathology
Humans
Isoenzymes
Myocardial Infarction / drug therapy*,  enzymology,  physiopathology
Prospective Studies
Recombinant Proteins / administration & dosage
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / administration & dosage*
Chemical
Reg. No./Substance:
0/Isoenzymes; 0/Recombinant Proteins; 81669-57-0/Anistreplase; EC 2.7.3.2/Creatine Kinase; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polycystic kidney disease re-evaluated: a population-based study.
Next Document:  The influence of autonomic neuropathy on mortality in insulin-dependent diabetes.